Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)A D Wagner, P Buechner-Steudel, A Wein, et al.
ACS Central Science|April 27, 2026
Propellane Alkaloid Biosynthesis and Total Synthesis via Interrupted Reaction PathwaysJohn M Billingsley, Jiaming Ding, Allison T Hands, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institutionH Zincke, E J Bergstralh, M L Blute, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 11, 2016
Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassificationS Merkel, K Weber, R S Croner, et al.
Urology|April 1, 1996
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Annals of Neurology|April 1, 1983
Acute panautonomic neuropathyP A Low, P J Dyck, E H Lambert, et al.
The Journal of Urology|December 1, 1985
Percutaneous removal of kidney stones: review of 1,000 casesJ W Segura, D E Patterson, A J LeRoy, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
The Journal of Urology|November 7, 2001
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen eraA V D'Amico, R Whittington, S B Malkowicz, et al.
British Journal of Cancer|June 9, 2005
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancerM Moehler, A Eimermacher, J Siebler, et al.
Pageof 20